BIOVENTUS INC - A (BVS)

US09075A1088 - Common Stock

3.97  -0.02 (-0.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
430.9M
34.15%		512.1M
18.84%		N/A533.31M
EBITDA
YoY % growth
55.08M
-1.71%		11.8M
-78.58%		N/A92.443M
EBIT
YoY % growth
20.2M
-26.28%		-55M
-372.28%		N/A79.269M
Operating Margin
4.69%-10.74%N/A14.86%
EPS
YoY % growth
0.820.16
-80.49%		0.000.16

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.08
70.87%
Revenue
Q2Q % growth		119.56M
0.39%
EBITDA
Q2Q % growth		13.066M
EBIT
Q2Q % growth		10.429M
179.01%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.07
216.67%		0.020.05246.53%
Q3 2023
Q2Q % growth		 0.05
-37.50%		-0.020.07347.52%
Q2 2023
Q2Q % growth		 0.14
40.00%		0.000.14∞%
Q1 2023
Q2Q % growth		 -0.26
-750.00%		-0.15-0.11-71.62%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 120.8M
-6.14%		120.19M610K0.51%
Q2 2023
Q2Q % growth		 137.1M
-2.28%		130.53M6.57M5.03%
Q1 2023
Q2Q % growth		 119.1M
1.53%		117.75M1.35M1.15%
Q4 2022
Q2Q % growth		 125.8M
-3.53%		134.03M-8.23M-6.14%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%